860
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

, , , , , & show all
Pages 633-639 | Received 04 Feb 2019, Accepted 22 Apr 2019, Published online: 26 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Minxiao Chen, Chenchen Qian, Bo Jin, Chenghong Hu, Lingxi Zhang, Minshan Wang, Bin Zhou, Wei Zuo, Lijiang Huang & Yi Wang. (2023) Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma. Cancer Biology & Therapy 24:1.
Read now
Ahmad Hassan Ali, Jennifer Damman, Shamita B. Shah, Yinka Davies, Melissa Hurwitz, Mariam Stephen, Leta M. Lemos, Elizabeth J. Carey, Keith D. Lindor, Cynthia W. Buness, Leina Alrabadi, William E. Berquist & Kenneth L. Cox. (2020) Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 55:8, pages 941-950.
Read now

Articles from other publishers (19)

William H. Wheless & Mark W. Russo. (2024) Treatment of Primary Sclerosing Cholangitis Including Transplantation. Clinics in Liver Disease 28:1, pages 171-182.
Crossref
Ajaikumar B. Kunnumakkara, Mangala Hegde, Dey Parama, Sosmitha Girisa, Aviral Kumar, Uzini Devi Daimary, Prachi Garodia, Sarat Chandra Yenisetti, Oommen V. Oommen & Bharat B. Aggarwal. (2023) Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacology & Translational Science 6:4, pages 447-518.
Crossref
Timothy M. Panknin, Carol L. Howe, Meg Hauer, Bhanu Bucchireddigari, Anthony M. Rossi & Janet L. Funk. (2023) Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials. International Journal of Molecular Sciences 24:5, pages 4476.
Crossref
Kamal D. Moudgil & Shivaprasad H. Venkatesha. (2022) The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. International Journal of Molecular Sciences 24:1, pages 95.
Crossref
Ganesan Padmini Tamilarasi, Manikandan Krishnan, Govindaraj Sabarees, Siddan Gouthaman, Veerachamy Alagarsamy & Viswas Raja Solomon. (2022) Emerging Trends in Curcumin Embedded Electrospun Nanofibers for Impaired Diabetic Wound Healing. Applied Nano 3:4, pages 202-232.
Crossref
Michael Trauner & Claudia Daniela Fuchs. (2022) Novel therapeutic targets for cholestatic and fatty liver disease. Gut 71:1, pages 194-209.
Crossref
Yongli Li, Junjie Jiao, Yuanzheng Qi, Wanqi Yu, Shihui Yang, Jingjie Zhang & Jinghui Zhao. (2021) Curcumin: A review of experimental studies and mechanisms related to periodontitis treatment. Journal of Periodontal Research 56:5, pages 837-847.
Crossref
Hasriadi, Peththa Wadu Dasuni Wasana, Opa Vajragupta, Pornchai Rojsitthisak & Pasarapa Towiwat. (2021) Mechanistic Insight into the Effects of Curcumin on Neuroinflammation-Driven Chronic Pain. Pharmaceuticals 14:8, pages 777.
Crossref
Arghavan Memarzia, Mohammad R. Khazdair, Sepideh Behrouz, Zahra Gholamnezhad, Maryam Jafarnezhad, Saeideh Saadat & Mohammad H. Boskabady. (2021) Experimental and clinical reports on anti‐inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review . BioFactors 47:3, pages 311-350.
Crossref
Marta Mazzetti, Giulia Marconi, Martina Mancinelli, Antonio Benedetti, Marco Marzioni & Luca Maroni. (2021) The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities. Journal of Clinical Medicine 10:8, pages 1763.
Crossref
Mengzhi Zou, Aizhen Wang, Jiajie Wei, Heng Cai, Zixun Yu, Luyong Zhang & Xinzhi Wang. (2021) An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis. International Immunopharmacology 92, pages 107328.
Crossref
Renald Blundell & Joseph Ignatius Azzopardi. 2021. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 129 139 .
Kambiz Hassanzadeh, Lucia Buccarello, Jessica Dragotto, Asadollah Mohammadi, Massimo Corbo & Marco Feligioni. (2020) Obstacles against the Marketing of Curcumin as a Drug. International Journal of Molecular Sciences 21:18, pages 6619.
Crossref
Adam P. Buckholz & Robert S. BrownJr.Jr.. (2020) Cholangiocarcinoma. Clinics in Liver Disease 24:3, pages 421-436.
Crossref
Elisa Ceccherini, Antonella Cecchettini, Maria Aurora Morales & Silvia Rocchiccioli. (2020) The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies. Frontiers in Pharmacology 11.
Crossref
Ayesha ShahGraeme A. MacdonaldMark MorrisonGerald Holtmann. (2020) Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 115:6, pages 814-822.
Crossref
Brian M. Fung & James H. Tabibian. (2020) Cholangiocarcinoma in patients with primary sclerosing cholangitis. Current Opinion in Gastroenterology 36:2, pages 77-84.
Crossref
Masoud Nouri-Vaskeh, Hossein Afshan, Aida Malek Mahdavi, Leila Alizadeh, Xiude Fan & Mohammad Zarei. (2020) Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial. Complementary Therapies in Medicine 49, pages 102351.
Crossref
Vollono Laura, Falconi Mattia, Gaziano Roberta, Iacovelli Federico, Dika Emi, Terracciano Chiara, Bianchi Luca & Campione Elena. (2019) Potential of Curcumin in Skin Disorders. Nutrients 11:9, pages 2169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.